Nab-paclitaxel + Gemcitabine + VCN-01 oncolytic adenovirus (zabilugene almadenorepvec) for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jul 2026: Trial registered, NCT07701486
  2. 31 Jul 2026: Trial started, NCT07701486

The trials

NCT07701486: A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic Cancer

State
Under way
Phase
Phase 1 and Phase 2
People
6 planned
Started
31 Jul 2026
Primary completion
1 Aug 2027
Arms
High dose
Results
None posted
  1. 14 Jul 2026: Trial registered
  2. 31 Jul 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.